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Book Reviews
Reducing the Risk of Cancers
Open University Individual Study Pack P578S, Milton
Keynes: Open University, 1992.
How should an Open University course on 'Reducing the
Risk of Cancer' best present its subject matter? It might do
well to base itself on The Causes ofCancer by Doll and Peto.
This course, seemingly intended mainly for those in health
education, unfortunately does badly. The 'individual study
pack' consists of two readers (200 pages each), two audio
cassettes, an activity booklet (50 hours of activities) and a
workbook. The course dispenses not only with Doll and
Peto's book but with the analytical approach that the book
fosters, and adopts what seems to be an increasing trend in
contemporary education, sacrificing factual material for
opinion, controversy and discussion. We listen, for example,
to a 15-min consultation between 'Adam Forman', a general
practitioner, and 'Pam', a professional women (who lacks a
surname!), on Pam's eating habits ('make notes as you
listen'). We do not ask whether the advice would reduce the
risk of cancer, but we consider what techniques Adam uses
to persuade Pam, the main features of his plan and how Pam
is helped by Adam. Next we hear Adam and Pam talking
separately about the useful points of the consultation, and
finally we 'turn to our workbooks for feedback on this
activity'.
Even if we accept such one-to-one consultations with
healthy individuals as a realistic basis for preventing cancers
it is difficult to envisage the facile approach of the course
producing useful results. With such a large amount of
material on the prevention of cancer the dearth of factual
matter is alarming. There is scarcely more than a page on
mammographic screening for breast cancer, no account of
the trials, no estimate of the percentage reduction in breast
cancer mortality that is likely to result from the National
Screening Programme in Britain. With its inclination to
activity and discussion rather than reading and study the
course might encourage an informed discussion among its
students on whether the reduction in breast cancer mortality
justifies the costs of screening, and introduce formal means of
addressing the issue. But the activities are superficial.
Much of the interest in the subject of preventing cancer is
lost with the dilution of factual material. There is little on the
wide variation in incidence of many cancers around the
world, little on the genetics of cancer, little on theories of
exponential cancer growth or how an apparently early detec-
tion of cancer may represent just one doubling time of a
cancer that has experienced 30. Smoking gets more space, but
the approach remains superficial and judgement gives way,
even here, to a perceived need to present both sides of an
argument; thus a 'case for tobacco' is presented, which
includes the statement that 'the tobacco industry is philan-
thropic and generous'. There is a guide to monthly testicular
self-examipation, graphically illustrated but without discus-
sion on the lack of evidence that it would reduce mortality.
Consensus conferences are espoused rather than guidelines
on how an individual might assess evidence. We are told of
cancer-prone personality types, that emotionally suppressed
women develop breast cancer and controlled, conforming,
non-aggressive women develop gynaecological cancers, but
the difficulties in making such conclusions from psychological
assessments on cancer patients and controls are not dis-
cussed, nor the limited potential in prevention.
It is worrying to see the Open University trivialising an
important subject that should enthuse and stimulate, but the
trend is widespread, shared for example by some material
produced on behalf of the Department of Health. The end
result can only be to obfuscate the distinction between what
has been proven and what has not, to invite cynicism on
preventative measures and to weaken the impact of steps that
individuals, society and governments can take to reduce the
burden of cancers and other serious diseases.
M. Law
Therapy of Haemopoietic Neoplasia
Edited by E.J. Freireich & H. Kantarjian, New York: Marcel
Dekker, 1991, 456 pp. $150.00.
This book is unequivocally out of the M.D. Anderson stable
(14 out of the 15 authors are from there). That it is possible
to write such a book from a single institution at all is a
tribute to the tremendous contribution made there to cancer
therapy during its relatively short 50 year existence. The
book is a fitting statement of the M.D. Anderson philosophy
of developmental therapeutics, central to which, it must be
recorded, was the contribution over many years of Ken
McCredie, who has now sadly died. It is also unequivocally a
book for experts. There are no introductory concessions for
the novice, so those unfamiliar with the meaning of '3 + 7'
should proceed no further!
The book is divided into 11 chapters covering the major
haematopoietic disease groups - AML, MDS, ALL (adults
only), CGL, CLL, myeloma, HCL, Hodgkin's and NHL and
then two final chapters on supportive care and the manage-
ment of infectious complications. All the chapters are written
by acknowledged authorities in their field, and this is
reflected in the wealth of experience recorded here that makes
it very much a practising clinicians' book.
There are some imbalances. ALL - never a favourite M.D.
Anderson disease and the only chapter written by someone
from out of town - takes up only 16 pages of text, whereas
CGL takes up 70. The discussion of BMT in AML might be
regarded by the connoisseur as reflecting traditional M.D.
Anderson differences of opinion in this field, and to my mind
underplays the role of BMT in AML. However, those of us
who know and love the institution can forgive these little
peccadillos, as a vast amount of useful information is pres-
ented throughout the book in a clear fashion. I particularly
liked the use in some chapters of treatment guidelines for
subgroups of disease and for certain regimens, for example
when to use interferon as opposed to deoxycoformycin in
HCL.
The most difficult area to discuss and present clearly is
always NHL because of the heterogeneity of the disease.
Fernando Cabanillas, however, has written an excellent
account, although the mixture of Rappaport and Working
Formulation short-hand terms may be confusing at first sight
to UK and other European colleagues. I was surprised not to
read more about the platinum/Ara-C combinations (another
M.D. Anderson 'discovery') in this chapter, but was less
surprised to see no mention of allografting at all!
Supportive care has also made an important impact, par-
ticularly during high-dose intensification; indeed, the original
IBM cell separators were developed in conjunction with the
M.D. Anderson team. Short sections within the chapter dis-
cuss blood product support, the management oftumour lysis,
mucosistis and the emerging role of growth factors. Infect-
ions are dealt with in an unusual way - by disease group and
then again by site of infection, with a final section on pro-
phylaxis.
The whole book is heavily referenced and has a good
number ofdiagrams and illustrations to complement the text.
I can agree with the editors that it represents the current
'state of the art' for treatment, though for how long remains
to be seen. In conclusion, despite its price, I would stronglyBOOK REVIEWS 625
recommend this book to clinicians actually involved in day-
to-day therapeutic decisions for the treatment of
haematological malignancies. It is a book to have on your
shelf ready to hand and perhaps of less use to the general
reader outside the immediate field.
C.H. Poynton
Atlas of Breast Cancer
Edited by Daniel E. Hayes, London: Mosby Europe Ltd,
1993, £70.00.
This atlas is perhaps unusual in providing such a broad
resume of breast cancer, ranging from its biology and
epidemiology, to diagnosis and management. Though its size
precludes it from being fully comprehensive, the skilful use of
diagrams to schematically convey principles and data has
been employed to maximal effect. Any economy of words
does not detract from meaning and factual content, and the
book epitomises the edict that a diagram can often convey
more than 'a 1000 words'.
The diagrams are not only thoughtfully constructed to
provide a pictorial representation of principles and concepts,
but are also presented in a colourful and attractive form. In
addition to superlative diagrams, the book also contains
many colour photographs and radiological illustrations. The
deliberately slim text is succinct, pertinent and up-to-date.
Though in-depth discussion is not appropriate in this type of
work, the authors manage to expound current opinion and
knowledge and highlight controversial issues in a non-
dogmatic style but one which alludes to certain transatlantic
differences of both practice and philosophy.
The book consists of 12 chapters, of which those on
mammography and radiotherapy techniques constitute the
largest and most detailed sections. The latter includes criteria
for selection of patients for conservative surgery and dis-
cusses the relevance ofcompromised surgical margins and the
increasing emphasis being placed on extensive intraductal
carcinoma (EIC) changes as a predictor of recurrence. The
conservative option is championed, but no mention is made
of psychological morbidity being similar in patients undergo-
ing either conservative surgery or mastectomy. Furthermore,
it is implied that cosmesis following conservative surgery
does not deteriorate beyond a period of 3 years.
The introductory chapter emphasises the heterogeneity of
breast cancer and how heredity and environment combine to
produce multiple genetic changes varying from one individual
to another, hence leading to a spectrum of clinical
phenotypes. This has tended to undermine successful and
consensual treatment policies. This chapter also elegantly
illustrates the shift from the centrifugal theory of spread of
breast cancer to one of biological predeterminism, with the
concomitant increasing use of adjuvant therapy.
The section on epidemiology and development of breast
cancer concentrates on the newer biology rather than
ponderous epidemiological data. It is quite commendable
that a book of this size should contain such a clear and
enlightening section on oncogenes and carcinogenesis - the
diagrams are superior to many of those found in more
specialist molecular biological texts. These concepts may best
be represented schematically at this introductory level.
It is evident from the section on surgical management that
our American colleagues place much less confidence in
FNAC than is the case here in the UK. An incisional biopsy
is advocated for T2 lesions, which clearly then necessitates a
further definitive procedure. When a tumour (TO or TI) is
EIC positive, then either a 'wider excision' or a mastectomy
is performed, depending on patient choice. For those under-
going mastectomy, the option of immediate reconstruction is
usually offered using either (a) silicon implant, (b) latissimus
dorsi flap (LD) with or without implant or (c) transverse
rectus abdominis (TRAM) flap. There is no mention of
delayed reconstruction; some patients adjust to their mastec-
tomy and are content with an external prosthesis. Perhaps as
an expression of a 'can do' society, American women are
more likely to expect and accept primary immediate recon-
struction (as well as screening mammography).
The sections on pathology and benign breast disease are
well written and vividly illustrated. The various forms of
DCIS (comedo, cribriform, micropapillary, papillary and
solid) are especially well described, though the text on
'fibrocystic disease' might have benefited from inclusion of
the term 'ANDI' (abnormalities of normal development and
involution) in place of 'physiological alterations'.
For women aged 40-50 years, screening mammography
every 1-2 years is recommended - in accordance with policy
of the American Cancer Society. However, a recent Swedish
overview of trials showed a non-significant reduction in
relative risk, while other trials have revealed an excess of
mortality from screening within this age group. A recent
publication in the British Medical Journal (4 December) con-
cludes that these discrepancies of clinical practice may to
some extent reflect intercontinental cultural differences. In the
face of accumulating evidence of no significant benefit (Jour-
nal of the American Medical Association, 24 November),
screening within this particular age group may soon be aban-
doned in the USA.
Similarly, the sections on systemic and adjuvant therapy
reflect the views of the American Consensus Conference. The
principles of such therapies are thoroughly enunciated, but
management policy does not coincide entirely with British
practice. In particular, it is questioned whether node-
negative, ER-negative women over 50 years should receive
adjuvant tamoxifen, and whether adjuvant therapy should be
given to node-negative women under 50 years irrespective of
ER status. No comments are made regarding a subgroup of
premenopausal node-negative patients with relatively large,
poorly differentiated tumours who probably should receive
some form of adjuvant therapy. Possible benefits of com-
bined chemoendocrine therapy in patients over 50 years are
not mentioned. The authors illustrate the difference between
relative and absolute benefits of adjuvant treatment, thus
emphasising how a significant proportion of those receiving
this form of therapy have a low risk of relapse and therefore
actually achieve rather small absolute benefits. A British text
would probably have singled out the 11% of patients with
primary breast cancer whose survival is similar to an age-
matched control population - this group are unlikely to
benefit from adjuvant therapy.
The only notable omission from this atlas is a 'quality of
life' section, despite the emergence of psycho-oncology as an
important subspecialty on both sides of the Atlantic.
Notwithstanding the above comments, this is an excellent
and timely Atlas of Breast Cancer which should be of use to
a wide range of readers, including those studying for both
under- and post-graduate exams (for whom the brevity and
of the text and clarity of the diagrams will be much app-
reciated). Breast cancer has developed into a complex multi-
disciplinary specialty with an enormous literature base. It is
refreshing and delightful to encounter such a concise yet
authoritative book on this subject.
J.R. Benson
M. Baum